+499.5%
MRNA vs ELV
+34.8%
+464.6%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | ELV | Excess | Alpha |
|---|---|---|---|---|
| 1D | -2.2% | -1.8% | -0.5% | -1.7% |
| 7D | +5.5% | +3.3% | +2.2% | +4.5% |
| 30D | +158.7% | +4.2% | +154.6% | +155.8% |
| 3M | +182.1% | -0.1% | +182.2% | +181.1% |
| 6M | +151.8% | +41.3% | +110.6% | +119.3% |
| YTD | +393.6% | +17.4% | +376.1% | +352.8% |
| 1Y | +499.5% | +35.1% | +464.4% | +369.3% |
| All | +499.5% | +34.8% | +464.6% | +369.3% |
Cumulative growth
Daily Returns
Daily percentage return beside ELV.
Daily Out/Under-Performance
Portfolio return minus ELV return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × ELV return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded ELV wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling